Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: rituximab

Maintenance of Remission in ANCA-Associated Vasculitis

Paul A. Monach, MD, PhD  |  September 5, 2012

Relapses are common, but difficult to predict and prevent.

Filed under:ConditionsResearch RheumVasculitis Tagged with:ANCA-Associated VasculitisdrugGlucocorticoidsgranulomatosis with polyangiitisMethotrexatepatient careResearchrheumatologistrituximabVasculitis

Drug Updates: Lorcaserin, Acetaminophen, and More

Michele B. Kaufman, PharmD, BCGP  |  September 5, 2012

information on new approvals and medication safety

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisRheumatoid Arthritis Tagged with:acetaminophenAnkylosing SpondylitisApprovalsBiologicsdrugFDAPipelinePsoriatic ArthritisrituximabSafetySteroids

Inflammatory Myopathies in Children

Angela Byun Robinson, MD, and Ann M. Reed, MD  |  July 10, 2012

Treatment options and recent research for juvenile dermatomyositis.

Filed under:ConditionsOther Rheumatic Conditions Tagged with:ANA titerdrugHYDROXYCHLOROQUINEinflammationinflammatory myopathyintravenous immune globulinjuvenile dermatomyositisMethotrexatepatient carePediatricsrheumatologistrituximab

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 9, 2012

Information on new approvals and medication safety.

Filed under:AnalgesicsAxial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Ankylosing SpondylitisBiologicsbiophosphonatesdrugJAK inhibitorsjanus kinaseMethotrexateopioidPainRheumatoid arthritisrheumatologistrituximabSafetySystemic lupus erythematosustocilizumabTofacitinib

ACR Issues Guidelines, Recommendations for Lupus Nephritis, RA

Kathy Holliman  |  June 10, 2012

Detailed screening and treatment recommendations based on current evidence, extensive literature review.

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesFrom the CollegeRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicsdrugGlucocorticoidsGuidelinesLupusLupus nephritispatient careRheumatoid arthritisSystemic lupus erythematosustocilizumab

The State-of-the-Art of Rheumatology Symposium

Lara C. Pullen, PhD  |  June 10, 2012

Experts from across the nation describe the best clinical approaches to rheumatologic disease management.

Filed under:ConditionsGout and Crystalline ArthritisResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatoryColchicineGoutHYDROXYCHLOROQUINELupuspatient carepregnancyResearchRheumatoid arthritisrheumatologistSystemic lupus erythematosus

Clinical Opportunities at the 2012 ACR/ARHP Annual Meeting

Joel A. Block, MD  |  June 10, 2012

The Annual Meeting will provide numerous opportunities to learn the latest clinical findings in the field and to update their knowledge in all aspects of rheumatology.

Filed under:Career DevelopmentConditionsEducation & TrainingFrom the CollegeOther Rheumatic ConditionsProfessional TopicsSjögren’s Disease Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)BiologicsClinicaldrugEducationIgG4 related diseaserheumatologistrituximabSjogren's

Case Study: 66-Year-Old Man with Visual Loss, Headache, Hematuria, Chronic Sinusitis

Eli Miloslavsky, MD  |  May 8, 2012

A 66-year-old man presented to the hospital with left-sided visual loss, headache, hematuria, and symptoms of a chronic sinusitis.

Filed under:ConditionsVasculitis Tagged with:ANCAANCA-Associated VasculitisDiagnosisdrugGlucocorticoidsgranulomatosis with polyangiitishematuriaimagingrheumatologistrituximabTreatmentVasculitisvisual loss

ACR/ARHP Annual Scientific Meeting Plenary Highlights Targets and Treatments for Several Diseases

Vanessa Caceres  |  April 6, 2012

Promising therapeutic targets for rheumatic diseases were the focus of a plenary session here at the ACR/ARHP 2011 Annual Scientific Meeting in November. Presenters discussed discoveries and treatments for systemic sclerosis, rheumatoid arthritis, vasculitis, and Behçet’s disease.

Filed under:ConditionsMeeting ReportsResearch RheumRheumatoid ArthritisSystemic SclerosisVasculitis Tagged with:ACR/ARHP Annual MeetingJAK inhibitorsjanus kinaseRAResearchRheumatoid arthritisrituximabSclerodermasclerosisTreatmentVasculitis

Meet the Challenge of Primary CNS Vasculitis

Carlo Salvarani, MD, Robert D. Brown, Jr., MD, MPH, and Gene G. Hunder, MD  |  September 1, 2011

Diagnosis and treatment of this rare and poorly understood condition

Filed under:ConditionsPractice SupportQuality Assurance/ImprovementVasculitis Tagged with:central nervous systemDiagnostic CriteriaPathogenesispatient careTreatmentVasculitis

  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 45
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences